Your browser doesn't support javascript.
loading
Clinical and immunological features of 44 common variable immunodeficiency patients: the experience of a single center in Turkey
Nepesov, S; Aygun, FD; Firtina, S; Cokugras, H; Camcioglu, Y.
Afiliação
  • Nepesov, S; Instanbul University Cerrahpaşa. Faculty of Medicine. Department of Pediatrics. Division of Pediatric Allergy, Imunology and Infectious Diseases. Istanbul. Turkey
  • Aygun, FD; Instanbul University Cerrahpaşa. Faculty of Medicine. Department of Pediatrics. Division of Pediatric Allergy, Imunology and Infectious Diseases. Istanbul. Turkey
  • Firtina, S; İstanbul University. Aziz Sancar Experimental Medicine Research Institute. Istanbul. Turkey
  • Cokugras, H; Instanbul University Cerrahpaşa. Faculty of Medicine. Department of Pediatrics. Division of Pediatric Allergy, Imunology and Infectious Diseases. Istanbul. Turkey
  • Camcioglu, Y; Instanbul University Cerrahpaşa. Faculty of Medicine. Department of Pediatrics. Division of Pediatric Allergy, Imunology and Infectious Diseases. Istanbul. Turkey
Allergol. immunopatol ; 48(6): 675-685, nov.-dic. 2020. tab, graf
Article em En | IBECS | ID: ibc-199258
Biblioteca responsável: ES1.1
Localização: BNCS
ABSTRACT
INTRODUCTION AND OBJECTIVES: Common variable immunodeficiency (CVID) is one of the most prevalent forms of primary immunodeficiency characterized by hypogammaglobinemia. Its heterogeneous clinical features include recurrent respiratory tract infections and other complications such as gastrointestinal, autoimmunity, and lymphoproliferative disorders. The aim of this article is to evaluate the general characteristics of CVID patients. MATERIALS AND METHODS: Clinical and immunological features of 44 CVID patients were evaluated retrospectively with long-term follow-up. Patients who participated in the study were diagnosed according to the criteria of the European Society for Immunodeficiency Diseases (ESID). RESULTS: The median age at onset of symptoms was 2.75 years (range 6 months to 17 years), and the median age at diagnosis was 7.75 years (range 4-20 years). The average delay in diagnosis was 4.6 years (range 1-14 years). Positive family history was 18.2%. Before treatment, patients' median total serum IgG was 271.5mg/dL, median IgA was 7.5mg/dL, and median IgM was 21mg/dL. Infections were the most common clinical manifestation, and 63.6% of patients presented with sinopulmonary infection as the first manifestation. Bronchiectasis developed in 23 CVID subjects, while bronchiectasis was detected prior to CVID diagnosis in eight patients. All patients received immunoglobulin replacement therapy, and one patient died because of granulomatous lymphocytic interstitial lung disease (GLILD). CONCLUSIONS: CVID is a heterogeneous group of immunologic disorders with unknown etiology. There are significant differences in the clinical presentation and prevalence of CVID-related complications among countries. Local guidelines for diagnosis and clinical follow-up are needed
RESUMEN
No disponible
Assuntos
Buscar no Google
Coleções: 06-national / ES Base de dados: IBECS Assunto principal: Imunodeficiência de Variável Comum Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Asia Idioma: En Revista: Allergol. immunopatol Ano de publicação: 2020 Tipo de documento: Article
Buscar no Google
Coleções: 06-national / ES Base de dados: IBECS Assunto principal: Imunodeficiência de Variável Comum Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Asia Idioma: En Revista: Allergol. immunopatol Ano de publicação: 2020 Tipo de documento: Article